NASDAQ : MSLE
Satellos Bioscience Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 6.815 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 145.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 9.48M | 1.51M | 600.00K | 6.68M | 2.76M | 1.60M |
| Gross Profit | -9.48M | -1.51M | -600.00K | -6.68M | -2.76M | -1.60M |
| Selling, General & Admin | 9.43M | 8.03M | 6.04M | 5.03M | 3.47M | 1.31M |
| Research & Development | 16.92M | 16.92M | 13.76M | -33.51K | ||
| Amortization of Goodwill & Intangibles | 130.34K | |||||
| Operating Expenses | 26.34M | 24.95M | 19.80M | 5.03M | 3.47M | 2.17M |
| Operating Income | -35.82M | -26.46M | -20.40M | -11.71M | -6.23M | -3.77M |
| Interest Expense | -134.03K | -40.41K | ||||
| Interest & Investment Income | 1.60M | 1.36M | 1.00M | 1.01M | 46.55K | 6.31K |
| Currency Exchange Gain (Loss) | -232.00K | 398.00K | 1.67M | -876.10K | -51.72K | 4.65K |
| Other Non Operating Income (Expenses) | -3.00K | 757.00 | 2.22K | -8.46M | ||
| EBT Excluding Unusual Items | -34.46M | -24.70M | -17.73M | -11.71M | -6.23M | -12.25M |
| Asset Writedown | -2.90M | -2.13M | ||||
| Other Unusual Items | -322.57K | |||||
| Pretax Income | -34.46M | -24.70M | -20.63M | -12.03M | -8.36M | -12.25M |
| Income Tax Expense | 154.00K | 172.00K | 3.69K | |||
| Net Income | -34.61M | -24.87M | -20.63M | -12.03M | -8.37M | -12.25M |
| Net Income to Common | -34.61M | -24.87M | -20.63M | -12.03M | -8.37M | -12.25M |
| Shares Outstanding (Basic) | 17.39M | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
| Shares Outstanding (Diluted) | 17.39M | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
| EPS (Basic) | -1.99 | -1.70 | -2.16 | -1.67 | -2.81 | -6.11 |
| EPS (Diluted) | -1.99 | -1.70 | -2.16 | -1.67 | -2.81 | -6.11 |
| Free Cash Flow | -29.01M | -23.60M | -18.26M | -8.79M | -4.17M | -3.98M |
| Free Cash Flow Per Share | -1.67 | -1.62 | -1.91 | -1.22 | -1.40 | -1.99 |
| EBITDA | -35.82M | -26.45M | -20.38M | -11.70M | -5.98M | -3.64M |
| D&A For EBITDA | 5.00K | 4.00K | 15.00K | 5.30K | 249.00K | 130.93K |
| EBIT | -35.82M | -26.46M | -20.40M | -11.71M | -6.23M | -3.77M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 7.39M | 9.80M | 40.07M | 16.71M | 1.42M | 3.85M |
| Short-Term Investments | 54.45M | 17.91M | 8.47M | 13.27M | ||
| Cash & Short-Term Investments | 61.84M | 27.71M | 48.55M | 29.98M | 1.42M | 3.85M |
| Other Receivables | 783.00K | 370.00K | 435.00K | 441.46K | 192.11K | 417.22K |
| Receivables | 783.00K | 370.00K | 435.00K | 441.46K | 192.11K | 417.22K |
| Prepaid Expenses | 642.00K | 187.00K | 180.00K | 112.07K | 33.99K | 34.48K |
| Other Current Assets | 2.50M | 3.62M | 1.58M | 3.03K | 2.22K | |
| Total Current Assets | 65.76M | 31.88M | 50.74M | 30.53M | 1.65M | 4.30M |
| Property, Plant & Equipment | 7.00K | 5.00K | 4.00K | 14.39K | 5.91K | 6.47K |
| Long-Term Investments | 31.05K | 31.03K | ||||
| Other Intangible Assets | 2.97M | 2.89M | 5.64M | |||
| Total Assets | 65.77M | 31.89M | 50.75M | 33.54M | 4.58M | 9.95M |
| Accounts Payable | 1.67M | 1.77M | 2.06M | 787.50K | 1.08M | 892.00K |
| Accrued Expenses | 4.16M | 1.96M | 1.01M | 770.60K | ||
| Current Income Taxes Payable | 30.00K | 72.00K | ||||
| Other Current Liabilities | 2.26M | 1.52M | ||||
| Total Current Liabilities | 5.86M | 4.11M | 3.58M | 2.74M | 2.09M | 1.66M |
| Total Liabilities | 5.86M | 4.11M | 3.58M | 2.74M | 2.09M | 1.66M |
| Common Stock | 133.95M | 85.83M | 78.13M | 46.88M | 22.32M | 22.38M |
| Additional Paid-In Capital | 11.78M | 10.17M | 7.90M | 6.44M | 2.72M | 976.33K |
| Retained Earnings | -103.46M | -81.97M | -57.10M | -35.97M | -23.36M | -16.03M |
| Comprehensive Income & Other | 17.63M | 13.76M | 18.23M | 13.45M | 801.67K | 965.55K |
| Shareholders' Equity | 59.91M | 27.78M | 47.16M | 30.80M | 2.49M | 8.28M |
| Total Liabilities & Equity | 65.77M | 31.89M | 50.75M | 33.54M | 4.58M | 9.95M |
| Net Cash (Debt) | 61.84M | 27.71M | 48.55M | 29.98M | 1.42M | 3.85M |
| Net Cash Per Share | 3.56 | 1.90 | 5.08 | 4.16 | 0.48 | 1.92 |
| Filing Date Shares Outstanding | 21.22M | 20.83M | 13.82M | 9.40M | 3.48M | 2.75M |
| Total Common Shares Outstanding | 20.84M | 15.46M | 13.82M | 9.40M | 3.48M | 2.75M |
| Working Capital | 59.90M | 27.78M | 47.16M | 27.79M | -441.11K | 2.64M |
| Book Value Per Share | 2.87 | 1.80 | 3.41 | 3.28 | 0.71 | 3.01 |
| Tangible Book Value | 59.91M | 27.78M | 47.16M | 27.83M | -404.16K | 2.64M |
| Tangible Book Value Per Share | 2.87 | 1.80 | 3.41 | 2.96 | -0.12 | 0.96 |
| Machinery | 9.61K | 7.97K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -34.61M | -24.87M | -20.63M | -12.03M | -8.37M | -12.25M |
| Depreciation & Amortization | 5.00K | 4.00K | 15.00K | 5.30K | 249.00K | 130.93K |
| Asset Writedown & Restructuring Costs | 2.90M | 2.13M | ||||
| Loss (Gain) From Sale of Investments | -31.03K | |||||
| Stock-Based Compensation | 3.41M | 3.23M | 1.64M | 1.64M | 1.06M | 767.71K |
| Other Operating Activities | 100.00K | -484.00K | -1.43M | 1.33M | 49.50K | 7.76M |
| Change in Accounts Receivable | 31.71K | |||||
| Change in Accounts Payable | 3.06M | 501.00K | 1.01M | 601.23K | 536.42K | -308.55K |
| Change in Other Net Operating Assets | -1.03M | -1.98M | -1.76M | -321.82K | 195.80K | -106.91K |
| Operating Cash Flow | -29.00M | -23.60M | -18.25M | -8.77M | -4.17M | -3.98M |
| Capital Expenditures | -7.00K | -6.00K | -4.00K | -13.63K | -2.22K | -5.73K |
| Cash Acquisitions | 1.38M | |||||
| Investment in Securities | -54.56M | -9.41M | 4.66M | -13.27M | ||
| Investing Cash Flow | -54.57M | -9.42M | 4.66M | -13.28M | -2.22K | 1.37M |
| Short-Term Debt Issued | 1.81M | |||||
| Long-Term Debt Issued | 147.43K | |||||
| Total Debt Issued | 1.81M | 147.43K | ||||
| Short-Term Debt Repaid | -1.99M | |||||
| Total Debt Repaid | -1.99M | |||||
| Net Debt Issued (Repaid) | -180.22K | 147.43K | ||||
| Issuance of Common Stock | 48.13M | 2.24M | 30.66M | 26.62M | 1.47M | 5.74M |
| Other Financing Activities | 4.65M | 6.92M | 11.74M | 575.58K | ||
| Financing Cash Flow | 52.78M | 2.24M | 37.57M | 38.19M | 2.05M | 5.89M |
| Foreign Exchange Rate Adjustments | -43.00K | 503.00K | -586.00K | -880.64K | -56.15K | -1.14K |
| Net Cash Flow | -30.82M | -30.27M | 23.39M | 15.25M | -2.18M | 3.28M |
| Free Cash Flow | -29.01M | -23.60M | -18.26M | -8.79M | -4.17M | -3.98M |
| Free Cash Flow Per Share | -1.67 | -1.62 | -1.91 | -1.22 | -1.40 | -1.99 |
| Levered Free Cash Flow | -16.92M | -14.76M | -11.72M | -5.49M | -1.85M | -125.71K |
| Unlevered Free Cash Flow | -16.92M | -14.76M | -11.72M | -5.41M | -1.85M | -100.46K |
| Change in Working Capital | 2.10M | -1.48M | -753.00K | 279.41K | 732.22K | -383.76K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 137.42M | 89.30M | 95.65M | 36.73M | 6.79M | 26.07M |
| Enterprise Value | 74.57M | 54.13M | 79.38M | 3.21M | 4.48M | 21.12M |
| Last Close Price | 6.40 | 5.88 | 7.08 | 3.90 | 2.06 | 9.72 |
| PB Ratio | 2.29 | 3.21 | 2.03 | 1.19 | 2.73 | 3.15 |
| P/TBV Ratio | 2.29 | 3.21 | 2.03 | 1.32 | 9.86 | |
| Net Debt / Equity Ratio | -1.03 | -1.00 | -1.03 | -0.97 | -0.57 | -0.47 |
| Net Debt / EBITDA Ratio | 1.73 | 1.05 | 2.38 | 2.56 | 0.24 | 1.06 |
| Net Debt / FCF Ratio | 2.13 | 1.17 | 2.66 | 3.41 | 0.34 | 0.97 |
| Quick Ratio | 10.69 | 6.84 | 13.67 | 11.08 | 0.77 | 2.57 |
| Current Ratio | 11.22 | 7.77 | 14.16 | 11.13 | 0.79 | 2.59 |
| Return on Equity (ROE) | -70.45% | -66.37% | -54.71% | -72.15% | -163.48% | -301.13% |
| Return on Assets (ROA) | -41.89% | -40.02% | -31.27% | -38.28% | -56.08% | -43.45% |
| Return on Capital Employed (ROCE) | -59.80% | -95.20% | -43.20% | -38.00% | -250.20% | -45.50% |
| Earnings Yield | -31.56% | -27.86% | -21.57% | -32.76% | -123.13% | -46.99% |
| FCF Yield | -21.11% | -26.43% | -19.09% | -23.92% | -61.40% | -15.28% |
| Buyback Yield / Dilution | -46.32% | -52.60% | -32.84% | -142.17% | -48.20% | -35.60% |